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Abstract
Background Conflict has played a role in the large-
scale deterioration of health systems in low-income and
middle-income countries (LMICs) and increased risk of
infections and outbreaks. This systematic review aimed
to synthesise the literature on mechanisms of delivery
for a range of infectious disease-related interventions
provided to conflict-affected women, children and
adolescents.
Methods We searched Medline, Embase, CINAHL and
PsychINFO databases for literature published in English
from January 1990 to March 2018. Eligible publications
reported on conflict-affected neonates, children,
adolescents or women in LMICs who received an infectious
disease intervention. We extracted and synthesised
information on delivery characteristics, including delivery
site and personnel involved, as well as barriers and
facilitators, and we tabulated reported intervention
coverage and effectiveness data.
Results A majority of the 194 eligible publications
reported on intervention delivery in sub-Saharan Africa.
Vaccines for measles and polio were the most commonly
reported interventions, followed by malaria treatment.
Over two-thirds of reported interventions were delivered
in camp settings for displaced families. The use of clinics
as a delivery site was reported across all intervention
types, but outreach and community-based delivery
were also reported for many interventions. Key barriers
to service delivery included restricted access to target
populations; conversely, adopting social mobilisation
strategies and collaborating with community figures
were reported as facilitating intervention delivery. Few
publications reported on intervention coverage, mostly
reporting variable coverage for vaccines, and fewer
reported on intervention effectiveness, mostly for malaria
treatment regimens.
Conclusions Despite an increased focus on health
outcomes in humanitarian crises, our review highlights
important gaps in the literature on intervention delivery
among specific subpopulations and geographies. This
indicates a need for more rigorous research and reporting
on effective strategies for delivering infectious disease
interventions in different conflict contexts.
PROSPERO registration number CRD42019125221.

Key questions
What is already known?
►► Conflict has especially devastating consequences

for the implementation and delivery of health interventions for women, children and adolescents, including infectious disease interventions.
►► Often, there are resurgences of infectious diseases
such as HIV transmission, polio, measles and other
vaccine-preventable diseases due to severed access
to standard prevention and treatment services.

What are the new findings?
►► In many conflict settings, coverage rates of infec-

tious disease interventions are challenging to ascertain and are often unknown.
►► Health workers, and the infrastructure and systems that support them, are debilitated by conflict.
Prioritising local communities’ needs and working
collaboratively with multiple sectors to develop holistic and sustainable solutions that address security
concerns is crucial in restoring operational functions
to deliver essential infectious disease services.

What do the new findings imply?
►► High-
quality

research is required to identify
evidence-based infectious disease interventions to
further support its provision and uptake in conflict-
affected settings.
►► There must be a greater focus on enhancing the
availability of health data, as it relates to infectious
diseases, of women and children in conflict settings.
Accessible and timely data will encourage accountability and aid in the coordination of multiple actors
across country, regional and global levels.

Introduction
Significant gaps in access to infectious disease
interventions within health systems exist globally and are further impeded by war, civil
unrest and political violence.1 The populations most vulnerable to infectious disease
transmission are those who are relegated to
live in crowded conditions with inadequate
shelter, poor sanitation, insufficient water
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quality and quantity, limited food security and a lack of
access to essential healthcare services.2 These risk factors
are major contextual determinants of child malnutrition,
outbreaks of communicable diseases and low immunisation coverage in many low-income and middle-income
countries (LMICs).3 Damage to sanitation facilities or a
scarcity of clean water means that water-borne and vector-
borne diseases are transmitted rapidly. Moreover, conflict-
affected countries are potential zones of new emergence
such as the case of Ebola imported into the Democratic
Republic of Congo (DRC), and conflict often triggers the
resurgence of previously controlled vaccine-preventable
diseases (VPD) due to severed access to standard prevention and treatment services.4 5 For instance, despite fairly
high preconflict VPD vaccination coverage rates in Syria,
reports of measles outbreaks and acute flaccid paralysis
related to poliovirus have become increasingly common.6
UNICEF figures show that in Syria, routine administration of first-
dose measles-
containing-vaccine decreased
from 82% coverage in 2010 to 54% in 2014.7 Beyond
hindering the provision of routine immunisations and
treatment of acute conditions, the breakdown of a health
system and restricted access to medical supplies can also
disrupt the continuum of care for long-term treatment
courses such as for HIV or tuberculosis (TB).1
Similar to the case in LMICs where armed conflict is
absent, acute respiratory infections (ARI, most notably
pneumonia), TB, diarrhoea, measles and malaria
account for the highest morbidity among children in
crisis-affected populations.8 However, a lack of consensus
on effective intervention implementation strategies and
disrupted routine surveillance make it difficult to coordinate sound public health responses in such settings.9
To address this difficulty and help improve the quality
of humanitarian response, a group of non-governmental
organisations (NGOs) and the Red Cross and Red
Crescent Movement collectively developed a humanitarian charter and a set of minimum standards as part
of the Sphere Project initiated in 1997. Now in its fourth
edition, the Sphere Handbook outlines minimum standards
for humanitarian response across a range of sectors,
including WASH, shelter, health and nutrition. It also
outlines key actions for controlling infectious diseases in
emergency settings: (1) swiftly implementing prevention
measures; (2) establishing surveillance and reporting
systems; (3) active diagnosis and case management and
(4) outbreak preparedness and response in a timely and
efficient manner.10 However, the Sphere Handbook does not
sufficiently address how best to implement such actions,
and there is little evidence-based guidance on implementation available elsewhere.10
Stronger scientific evidence on implementing effective infectious disease interventions is needed to
effectively respond to humanitarian crises. Previous
reviews have systematically characterised the evidence
on the effectiveness of infectious disease interventions during humanitarian crises.11 12 Though there
has been increased international focus to produce and
2

disseminate systematic and comprehensive guidelines
for the delivery of infectious disease services in conflict
settings, significant challenges remain in terms of provision and utilisation of critical health interventions.13 This
paper is part of a set of eight systematic reviews using a
common protocol to examine the delivery of reproductive, maternal, newborn, child and adolescent health and
nutrition interventions in conflict settings, motivated by
the urgent need to better address the vulnerabilities of
women and children in humanitarian crises generally
and in conflict settings particularly.14 15 Here we aimed to
systematically characterise the literature on the delivery
of infectious disease interventions to women, children
and adolescents and identify key gaps in that literature;
and to synthesise reported information on intervention
delivery characteristics, including how they may vary by
setting and by population displacement status.
Methods
Search strategy
A systematic search of indexed literature published
from 1 January 1990 to 31 March 2018 was conducted
in Medline, Embase, CINAHL and PsychINFO databases
using OVID and EBSCO interfaces. The ‘Explode’ function for the Medical Subject Heading Terms was activated for main sets of terms related to three concepts:
(a) conflict; (b) women and children and (c) infectious
diseases. Conflict-
related search terms included war,
crisis, refugees, internally displaced person (IDP) and
stateless. Population-
related terms included newborn,
children, adolescents, women and pregnant. Infectious-
disease-
related terms included immunisation, cholera,
measles, HIV, TB and other disease terms. The complete
search syntax for Medline is presented in online supplementary appendix A. We also screened reference lists of
key systematic reviews conducted previously in the field
of humanitarian health.
For grey literature, we searched the websites of 10 major
humanitarian agencies and organisations that are actively
involved in responding to or researching conflict situations for reports on the delivery of health interventions
in our population of interest. These websites included
Emergency Nutrition Network, International Committee
of the Red Cross, International Rescue Committee,
Médecins Sans Frontières, Save the Children, United
Nations Population Fund, United Nations High Commissioner for Refugees, United Nations Children’s Fund,
Women’s Refugee Commission and World Vision. We
used broad terms for conflict and health interventions
tailored to the search functionality of each website. Grey
literature documents published from 1 January 2013 to
30 November 2018 were reviewed.
Eligibility criteria
Eligible publications were limited to those reporting
on populations affected by conflict in LMICs, as classified by the World Bank.16 The intervention must have
Meteke S, et al. BMJ Global Health 2020;5:e001967. doi:10.1136/bmjgh-2019-001967
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Figure 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram: publication selection process
for systematic review on the delivery of infectious disease interventions to women and children in conflict settings.

targeted or included neonates, children, adolescents or
women of reproductive age. The publication must have
also described an intervention being delivered during or
within 5 years of cessation of conflict. A 5-year cut-off was
applied to help ensure that we were capturing humanitarian rather than broader development contexts, and
assuming that it may take recovering LMICs up to 5 years
to be able to use foreign aid impactfully.17 If ongoing or
recent cessation of conflict was not referred to explicitly
in the publication, we consulted online encyclopaedic
sources as well as the UN Office for the Coordination of
Humanitarian Affairs website for information on conflict
duration, to assess whether the reported time period of
intervention delivery met the 5-year cut-off criterion. To
identify the most informative resources from the large
volume of grey literature that we retrieved even using
a shorter publication window, the same population and
Meteke S, et al. BMJ Global Health 2020;5:e001967. doi:10.1136/bmjgh-2019-001967

intervention delivery period criteria used for the indexed
literature were applied, along with an additional requirement of explicit reporting in the grey literature on the
delivery site and personnel for each intervention.
Non-
English publications; case reports of single
patients; publications reporting on military personnel,
refugee populations bound for a high-income country,
surgical techniques, economic or mathematical modelling; and editorials and opinion pieces were excluded
from our review. Other exclusion criteria included
systematic reviews, guidelines and publications where
no specific health intervention was described (eg, prevalence studies).
Data extraction and analysis
All identified indexed records were downloaded into
EndNote software and duplicates were removed. Unique
3
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records were then imported into Covidence software
for screening. Titles and abstracts were screened for
relevance in duplicate, and the full-text of each potentially relevant publication was then screened by a single
reviewer who noted reasons for exclusion at this stage.
Relevant information and data from the eligible
indexed and grey literature were extracted in duplicate
into a customised and piloted form using REDCap software. Key variables included publication author, publication year, study design, setting, target population
characteristics, intervention characteristics and delivery
characteristics, including any author-reported narrative
information on delivery barriers or facilitators. We also
extracted reported quantitative data on intervention
coverage and effectiveness (eg, sample size, point estimates, SD or errors, 95% CIs, p-values). The double-entry
data were matched and any discrepancies were resolved
through discussion, or by a third reviewer if needed.
We generated descriptive statistics to summarise key
population and intervention characteristics, including
population displacement status and intervention delivery
characteristics, and we narratively synthesised factors
inhibiting or facilitating the implementation of interventions by grouping reported information into common
themes. We tabulated reported quantitative data on
coverage and effectiveness; given the wide range of interventions, geographic settings, populations and delivery
approaches across the publications, we did not undertake
meta-analysis.
Results
A total of 37 436 unique citations were retrieved from
indexed databases, with 170 ultimately assessed as eligible
(figure 1). From the screening and assessment of the grey
literature and of the reference lists of relevant systematic
reviews, a further 24 eligible publications were identified.
From the total of 194 eligible publications18–211 included
in our review (table 1; online supplementary appendix
B), we captured 392 reported instances of infectious
disease intervention delivery. Publication frequency
varied since the beginning of the review study period in
1990, with peaks in 1996 and again in 2013 (n=26), and
remaining high since then (figure 2). The frequency of
reported intervention start years also varied, with a peak
in 1994 relating to the genocide in Rwanda and a similar
peak in 2005 relating to civil war in DRC, and later peaks
in 2011 and 2013 relating to the conflict in Syria.
In regards to the geographic distribution of the
included publications, more than half reported on
intervention delivery in sub-
Saharan Africa (106/194,
55%), most frequently in the DRC, South Sudan, Sudan,
Tanzania and Ethiopia (figure 3). About 20% of included
publications (41/194) were focused in East Asia, with
Thailand accounting for the vast majority of these (36/41,
88%). South Asia (26 publications, 13%) and the Middle
East and North Africa (15 publications, 8%) were the
next most frequent regions, with the fewest publications
4

Table 1 Summary of publication characteristics (n=194)*
Geographic region

n

Sub-Saharan Africa
East Asia and Pacific

106
41

South Asia

26

Middle East and North Africa

15

Europe and Central Asia

3

Latin America and the Caribbean

3

Publication type

n

Non-research report

44

Mixed methods

5

Observational

104

Non-randomised controlled trial

5

Randomised controlled trial

36

Target population type†

n

All/general population

115

All women

32

Pregnant women

16

Children<5 years only

27

Adolescents

0

Displacement status of beneficiary population†

n

IDPs

59

Refugees

102

Returning refugees

8

Non-displaced

45

Host

13

Unreported

16

Setting of displaced populations‡

n

Camp

101

Dispersed

26

Mixed
Unreported

30
3

*Refer to online supplementary appendix B for detailed information
on included publications.
†Publications may be included in more than one category.
‡Only reflects publications that reported on displaced populations
(refugees, IDPS, or returning refugees).
IDP, internally displaced person.

focusing in Latin America (three publications, 2%), only
consisting of El Salvador and Nicaragua, and Europe and
Central Asia (three publications, 2%), including Macedonia and Azerbaijan. Of the included publications,
53% reported on intervention delivery in refugee populations and 30% in IDP populations. Publications from
Uganda, South Sudan, DRC and Sudan predominantly
focused on delivery to IDPs; publications from Thailand,
Tanzania and Pakistan mostly focused on delivery to
refugees from neighbouring countries (figure 4). Nearly
80% of publications reporting on intervention delivery
Meteke S, et al. BMJ Global Health 2020;5:e001967. doi:10.1136/bmjgh-2019-001967
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Figure 2

Publications counts by (a) publication year and (b) intervention start year.

to conflict-affected populations that were not displaced
were focused in sub-Saharan Africa.
Overall, vaccines were the most commonly reported
intervention delivered (figure 5). For interventions
where there were mass immunisation campaigns, polio
Meteke S, et al. BMJ Global Health 2020;5:e001967. doi:10.1136/bmjgh-2019-001967

and measles vaccines were the most frequently reported
vaccines administered to children under five. These
high priority vaccines were often reported to be delivered in conjunction with one another. Vitamin A was
also frequently reported to be given in conjunction with
5
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Figure 3

Geographic distribution of included publications.

the measles vaccine. The delivery of cholera and diphtheria, tetanus and pertussis (DTP) vaccines were also
frequently reported. After vaccines, malaria treatment
was the second most commonly reported intervention, followed by screening for infectious diseases and
behaviour change or education interventions. Screening
for HIV or other sexually transmitted infections (STIs)
was often reported to be integrated into antenatal care.
Of the 49 reported instances of a screening intervention, 27 targeted HIV/STIs (56%), and 10 screened for
malaria (21%); the remaining were for TB referrals.
Behaviour change or education interventions accounted
for 12% of reported interventions delivered. Examples of these interventions included condom provision,
hygiene promotion and psychosocial support services.
About 62% of the 392 reported instances of intervention delivery occurred in camp settings, and about 30%
in non-
camp environments, with the remaining 8%
occurring among conflict-affected populations who were
not displaced. Among both refugees and IDPs, a large
majority of reported interventions were delivered within
camps compared with out of camps, particularly vaccines
(figure 5). The relative frequency of different intervention types was similar in both settings.
The delivery of interventions was categorised into three
tiers of the care continuum: ‘outpatient’, consisting of
delivery in hospitals and clinics; ‘outreach’, where service
mobility is a component, such as delivery through temporary health posts or mobile clinics and ‘community-
based’ care, which includes intervention delivery in
homes, markets, places of worship, schools or other
communal spaces (figure 6). Clinics were used as delivery
sites for all reported intervention types, but outreach and
6

community-based delivery were also common levels of
care for intervention delivery. In terms of home-based
delivery, malaria prevention interventions (eg, the distribution of insecticide-
treated nets and indoor residual
spraying) were the most frequently reported, while
vaccines were also often delivered at the home using door-
to-
door strategies. Reported behaviour change/education interventions were mostly delivered in community
settings, using the broadest range of delivery personnel
types (figure 7). UN/NGO staff and health workers were
the most frequently reported delivery personnel across
all displacement settings, including among those who
were non-displaced. Community health workers (CHWs)
most often delivered health interventions to homes.
Skilled birth attendants delivered interventions such as
prevention of mother-to-child transmission of HIV and
malaria treatment for pregnant women during antenatal
care services. In some cases, civic and religious leaders
were enlisted to encourage the uptake of polio vaccines
where communities were misinformed or where public
trust was compromised.185 212
Multiple barriers to implementing and scaling up the
delivery of infectious disease interventions in conflict
settings were highlighted in the included literature
(table 2). Many of the obstacles revolved around limited
access to target populations due to active combat, as well
as logistical constraints, especially with the procurement
and storage of vaccines. Public trepidation and reluctance to use health services delivered by foreign agencies
also presented as a common barrier accounting for lower
than expected coverage of some interventions. Other key
barriers to delivery included a shortage of trained health
workers, as well as stigma for receiving treatment for
Meteke S, et al. BMJ Global Health 2020;5:e001967. doi:10.1136/bmjgh-2019-001967
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Figure 4 Geographic distribution of included publications by population displacement status. IDPs, internally displaced
persons.

certain illnesses considered taboo, like HIV for example.
Multiple strategies to counter some of these barriers were
also documented in the literature. The most notable
facilitator to implementing interventions was adopting
social mobilisation strategies by coordinating a multisectorial approach. This was accomplished in out-of-camp
settings by working with the Ministry of Health, engaging
prominent local leaders, including CHWs in intervention
delivery and integrating health promotion programmes
at the community level to ensure accurate and harmonised messaging. Instituting reliable surveillance and
population data in camp settings was also crucial for the
roll-out of interventions. Some other common facilitators were capacity building—enriching the knowledge
and practical skills of local workers, and ensuring that
Meteke S, et al. BMJ Global Health 2020;5:e001967. doi:10.1136/bmjgh-2019-001967

intervention delivery had an outreach component so it
was flexible to move with populations.
Only 15% of included publications (30/194) reported
data on intervention coverage. Most reported on coverage
data related to vaccinations, especially polio vaccines for
children under 5 years and measles vaccine for those
under 15 years, with some data available on cholera,
DTP, tetanus, meningitis and TB vaccination coverage
(online supplementary appendix C). Reported coverage
rates for polio and measles vaccines often exceeded
80%. There was no observable difference between polio
and measles coverage by displacement status or setting.
Only 7% of publications (13/194) reported data on
intervention effectiveness, most frequently evaluating
malaria treatment regimens including different dosages
7
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Figure 5

Frequencies of reported interventions delivered (a) overall, (b) in camps and (c) out of camps.

of antimalarial medications, and malaria prevention
interventions including insecticide-treated bednets and
clothing.
Discussion
Principal findings
This systematic review identified 194 publications from
1990 to 2018 that report on delivery modalities of infectious disease interventions for women, children and
adolescents in conflict-
affected zones. While a range
of delivered interventions was reported in the literature, interventions for vaccine-
preventable diseases
predominated, particularly for polio and measles virus.
8

Malaria treatment in Thailand and infectious disease
screening, especially for HIV across sub-Saharan Africa,
were also reported frequently. Though clinic-
based
delivery was evident for all intervention types reported,
many reported interventions were also delivered using
outreach approaches, highlighting the advantage of
mobile health services in many conflict settings. Due
to the constraints of maintaining and accessing static
clinics in areas of armed conflict, and because of high
population movement, health personnel often provided
interventions through the installation of health posts and
mobile clinics. Moreover, most reported interventions
were delivered in camps, likely reflecting the generally
Meteke S, et al. BMJ Global Health 2020;5:e001967. doi:10.1136/bmjgh-2019-001967
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Figure 6

Reported intervention delivery sites. DTP, diphtheria, tetanus and pertussis; TB, tuberculosis.

higher access to target populations in these settings, but
perhaps also reflecting greater documentation of health
service delivery in camp sites than in other settings. Few
publications provided estimates for intervention coverage
and effectiveness, with data for vaccine coverage being
most commonly reported. Most of the reported intervention coverage and effectiveness data were captured
from people living in camp settings. Multiple publications reported that collaboration through participatory
processes involving prominent community actors, and
modifying interventions to adapt to the cultural and religious context led to added coverage and impact. This
includes inviting key stakeholders and respected community leaders to design programmes and assist with the
dissemination and delivery of interventions.213
Evidence gaps
The results of this review highlight several important gaps
in the literature, relating to populations, geography and
targeted health conditions. Very few publications were
included from Latin America, with none from Colombia,
despite having the most severe internal displacement
situation in the world,214 or from other conflict-affected
countries in the region such as Honduras, Nicaragua
and El Salvador. Despite the need for adolescent-focused
sexual and reproductive health programming including
Meteke S, et al. BMJ Global Health 2020;5:e001967. doi:10.1136/bmjgh-2019-001967

HIV/STI prevention and treatment in humanitarian
settings,213 we found no reporting on infectious disease
interventions targeting adolescents, and therefore no
evidence on coverage rates in this population group. That
much of the included literature focuses on the delivery
of polio and measles vaccination is also not surprising.
Poliovirus is of great concern in humanitarian crises as
the move towards eradication is stalled when immunisation coverage is threatened by conflict; polio eradication
relies on accessing over 95% of children with vaccines.
Disturbances to routine immunisation and surveillance
systems rapidly reduce population immunity, inevitably
making individuals more susceptible to polio outbreaks.
Measles is also of concern due to its highly contagious
nature, especially among young children. Considering
the mode of transmission, measles outbreaks are exacerbated by conflict and inhabiting overcrowded spaces.215
Nonetheless, the very limited reporting on the delivery of
interventions for other important infectious disease conditions in the context of conflict is disproportional. Only
one publication reported on the delivery of interventions
for ARI including pneumonia, despite ARI morbidity
often being very high in crowded camp settings.216 There
was also limited reporting of neglected tropical disease
(NTD) interventions, despite the elimination of NTDs by
9
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Figure 7

Reported intervention delivery personnel. DTP, diphtheria, tetanus and pertussis; TB, tuberculosis.

2020 being a global goal. The major NTD focus in the
literature was visceral/cutaneous leishmaniasis, likely
due to the high morbidity and striking symptomology of
the condition. Many NTDs often spike during warfare,
with displacement in densely populated spaces, but very
few publications reported on trachoma, deworming or
other NTD interventions.217
Limitations
Previous reviews of the literature have examined the size
and quality of the evidence base for infectious disease
interventions delivered in humanitarian settings,11 12 but
this review is the first, to our knowledge, to focus on the
mechanisms of intervention delivery to women and children affected by armed conflict. Nonetheless, this systematic review has several limitations. Methodologically,
our decision to restrict the eligible literature to reports
published only in English means that key information
may have been missed, considering many conflicts occur
in regions where English is not widely spoken and many
humanitarian organisations operate and may document
their operations in languages other than English. Our
inclusion of interventions delivered within 5 years of the
cessation of a conflict means that some interventions
delivered during peacetime may also have been included
10

inadvertently, potentially biassing our findings on how
and by whom these interventions have been delivered in
conflict settings and what the key delivery barriers and
facilitators have been. The vast majority of the publications included in our review referred explicitly to delivery
in a conflict context however, and so we would expect
the influence of peacetime intervention delivery on our
findings to be minimal. Furthermore, our approach in
conducting a comprehensive but not exhaustive search
of the grey literature means that we will have excluded
other relevant publications, some of which may have
provided different information on intervention delivery
than what we have currently captured.
Beyond the limitations of our methodological
approach, several limitations derive from the nature of
the literature itself: much humanitarian health action
goes undocumented and is not evaluated, and so it is
not possible to estimate how well the infectious disease
interventions and delivery patterns that have been
reported and are captured here actually reflect those on
the ground. Specifically, reporting on the coverage and
effectiveness of these interventions was very poor. This
major gap is likely due to multiple factors that make
the monitoring and evaluation of intervention delivery
Meteke S, et al. BMJ Global Health 2020;5:e001967. doi:10.1136/bmjgh-2019-001967
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Table 2 Barriers and facilitators to the delivery of infectious disease interventions in conflict settings
Barriers
General themes

Examples

Constrained access

Difficulty accessing target populations due to ongoing conflict, insecurity and armed insurgency. This includes bans
on health services and attacks on health workers by antigovernment groups or armed militia.
A challenging physical environment, for example: rainy seasons, winter weather or long distances.

Community buy-in

Lack of community support and political hesitancy to embrace health campaigns from foreign agencies.
Mistrust and misinformation from local community members, particularly around the administration of polio vaccines.

Poor infrastructure

Destruction of health infrastructure and a lack of transit centres along borders, causing limited access to facilities for
care provision.
Displaced persons who established living quarters in crowded areas with scarce sanitation and poor water supply,
further facilitating an environment for the spread of highly infectious diseases like measles and poliovirus.

Logistics

Logistical problems with supply chain, specifically with the storage and shipment of vaccines to various vaccination
sites.
Resource constraints and rising costs due to the high demand of services, resulting in a shortage of diagnostic tools,
drugs and equipment.

Human resources

Ongoing violence in conflict countries induced an exodus of thousands of doctors and nurses, seriously threatening
the already strained health system.
Major turnovers of international staff, a shortage of trained health workers and the presence of inexperienced teams
during the early phases of an intervention contributed to delays in service delivery.

Stigma

Challenges noted with introducing HIV care into areas with minimal HIV knowledge; concerns that people diagnosed
as HIV-positive could face serious negative consequences (eg, abandonment, physical violence, discrimination).
Language barriers with care providers, and a fear of stigmatisation for receiving services for other taboo illnesses.

Mobile populations

High patient mobility was challenging for ensuring the continuity of care, particularly for HIV and TB treatment.
Frequent movements of conflict-affected populations also accounted for lower than expected screening members and
limited vaccination coverage during immunisation efforts.

Facilitators
Social mobilisation

Forming strong partnerships with local community leaders (eg, elders, civic and religious figures) who leveraged their
influence to negotiate access and promote community uptake of health interventions.
Swift coordination with Ministry of Health or other partners in developing comprehensive operational plans to allocate
resources quickly and efficiently.
Employing strategies to provide knowledge to population; guided by promotion efforts (eg, radio broadcasting,
precampaign focus-group interviews, etc)

Capacity building

Providing skills training to enrich and strengthen the role of CHWs and other national staff who are most familiar with
the context; particularly useful for behavioural change/education and screening interventions.
Optimising the use of pre-existing resources, facilities and tools with limited resources.

Safeguards and
resource provision

Ensuring sufficient and working equipment for communication and feedback (eg, telephone/internet connection,
camera, copier machine and computers). As well as obtaining sufficient resources and long-term commitment from
aid agencies.
Regular monitoring of the security situation and adapting contingency plans; allowing patients/staff coming from
distant locations to stay near project sites.

Operational mobility

Flexibility to move ‘temporary fixed posts’ (ie, mobile clinics, health posts), frequently in response to caregivers’
demand to bring interventions (specifically vaccines) closer to their homes.
Working within closed camps or areas with restricted movement of populations helped to ensure intervention
coverage and the continuity of care.

Reliable surveillance

Instituting sustainable and reliable infectious disease surveillance helped to guide health planning for refugee
populations.
Detailed mapping of population settlements and their movements, aided in identifying communities with the largest
target populations.

Negotiating ceasefires Negotiating cease-fire or tranquillity days between warring factions, particularly for national immunisation days,
allowing health workers to vaccinate children in areas with ongoing conflict.
CHWs, community health workers.

difficult in conflict settings, including insecurity, high
population mobility and a lack of both human and logistical resources to reliably and systematically collect and
analyse quality data. Where coverage or effectiveness data
were reported, very few publications reported gender-
disaggregated data, precluding any analysis of potential
gender differences. Further, where documentation of
delivered interventions does exist (often in non-research
Meteke S, et al. BMJ Global Health 2020;5:e001967. doi:10.1136/bmjgh-2019-001967

reports or in cross-sectional studies), detailed information is rarely presented on how those interventions were
delivered (eg, where and by whom, overcoming what
barriers with what facilitators) or on their coverage or
effectiveness. Finally, we must recognise that the highly
contextual nature of humanitarian crises, with great variation geographically, socially, culturally and politically,
can produce considerable heterogeneity in intervention
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delivery patterns and even intervention effectiveness
across settings.
Potential implications of findings for programming and future
research
The limited information available on how such interventions are currently being delivered, and the paucity
of data on achieved intervention coverage and effectiveness make recommendations on delivery strategies for
different conflict contexts difficult to make. Our results
strongly indicate that more rigorous and timely research
is needed to identify effective strategies for delivering
evidence-
based infectious disease interventions in
different conflict contexts. Future data collection should
also enable gender analyses to be undertaken, to investigate gendered differences in health needs, access and
uptake of services.
There is much variation in practice across UN/NGOs
in programming for infectious disease interventions,
suggesting a need for further consensus-
building to
develop a comprehensive set of standard operating procedures and implementation protocols for intervention
delivery that could be accessed, adapted and applied in
different conflict contexts. In the meantime, it is evident
that infectious disease intervention planning must
include components to addresses the security concerns
of health service beneficiaries as well as providers, with a
focus on restoring pre-existing facilities and operational
functions that deliver essential services. At a broader
level, preventing attacks on healthcare facilities and
staff requires sustained effort at international, national
and community levels. Moreover, garnering support
and acceptance from local communities and influencers, including local authorities, appears to be critical,
suggesting that health actors should aim to educate those
around them while maintaining the perception of their
impartiality and neutrality;218 219 further work to identify
effective and efficient ways of doing this may be similarly
critical. Further training and counselling of less-skilled
health workers to enable appropriate task-
shifting/
sharing is required to better exploit delivery opportunities along the continuum of care, including community-
based delivery.
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